This inventor holds 1 USPTO granted patent. Top assignee: Nongshim Co., Ltd. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Chang Won Ahn: Innovator in Angiotensin Converting Enzyme Inhibitors
Introduction
Chang Won Ahn is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of angiotensin converting enzyme inhibitors. His work focuses on creating safe and effective compounds derived from foodstuffs.
Latest Patents
Chang Won Ahn holds a patent for an angiotensin converting enzyme inhibitor that is derived from foodstuff. This invention is characterized by its high activity and safety, making it suitable for mass production. The patent includes compounds with the formula (1) His-His-Leu or (2) His-Leu-Leu, along with their physiologically acceptable salts. He has 1 patent to his name.
Career Highlights
Ahn is currently employed at Nongshim Co., Ltd., a company known for its innovative food products. His role involves research and development, where he applies his expertise in biochemistry to create new pharmaceutical solutions.
Collaborations
Throughout his career, Chang Won Ahn has collaborated with notable colleagues, including Hyung J Lee and Jae Ik Shin. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Chang Won Ahn is a distinguished inventor whose work in angiotensin converting enzyme inhibitors showcases his commitment to innovation in the pharmaceutical industry. His contributions are paving the way for safer and more effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile